Results 171 to 180 of about 47,059 (243)

Concurrent Use of Extra‐Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine: A Cohort Study of Urban Adults Who Have Injected Drugs

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction In a policy environment with constrained access to the medications for opioid use disorder (MOUD), we examined the prevalence and correlates of extra‐medical use of these medications among individuals already prescribed MOUD.
Kyle J. Moon   +6 more
wiley   +1 more source

Payday Loan Use Among People With Lived and Living Experience of Substance Use

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Due to high‐penalty lending practices, short‐term, small‐dollar payday loans can trap borrowers in cycles of debt and reinforce socioeconomic disadvantage. People with lived and living experience of substance use (PWLLE) who often contend with financial and labour market exclusion and have relatively inflexible cash flow needs may
Allison Laing   +4 more
wiley   +1 more source

Cell type-specific multi-omics analysis of cocaine use disorder in the human caudate nucleus. [PDF]

open access: yesNat Commun
Zillich L   +21 more
europepmc   +1 more source

Client Engagement With an Early Psychosis Program and Post‐Program Health Service Use: A Retrospective Cohort Study

open access: yesEarly Intervention in Psychiatry, Volume 20, Issue 7, July 2026.
ABSTRACT Background Poor engagement with Early Intervention Services (EIS) for first‐episode psychosis threatens program effectiveness, yet research often reduces engagement to a binary measure (engaged/disengaged), limiting understanding of those who disengage and re‐engage.
Nathan K. Smith   +3 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms

open access: yesFundamental &Clinical Pharmacology, Volume 40, Issue 4, July 2026.
ABSTRACT Background Cocaine use disorder (CUD) remains a major public health concern, characterized by high relapse rates and the absence of approved pharmacological treatments. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA), widely prescribed for metabolic disorders, modulate mesolimbic reward pathways and have been proposed as potential ...
Céline Eiden   +7 more
wiley   +1 more source

A single-blind, randomized, controlled contingency management trial on physiological indices and biomarkers of cardiovascular health in people with cocaine use disorder. [PDF]

open access: yesDrug Alcohol Depend
Stoops WW   +11 more
europepmc   +1 more source

Understanding the patient and supporter journey in cocaine use disorder. [PDF]

open access: yesFront Psychiatry
Leclair D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy